Skip to main content
Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · IEX Real-Time Price · USD
8.47
-1.03 (-10.84%)
At close: Apr 25, 2024, 4:00 PM
8.82
+0.35 (4.13%)
Pre-market: Apr 26, 2024, 7:38 AM EDT

Acrivon Therapeutics Market Cap

Acrivon Therapeutics has a market cap or net worth of $261.49 million as of April 26, 2024. Its market cap has increased by 15.34% in one year.

Market Cap
261.49M
Enterprise Value
138.26M
1-Year Change
15.34%
Ranking
#3439
Category
Micro-Cap
Stock Price
$8.47

Market Cap Chart

Since the IPO on November 15, 2022, Acrivon Therapeutics's market cap has increased from $235.12M to $261.49M, an increase of 11.21%. That is a compound annual growth rate of 7.64%.

History

DateMarket Cap% Change
Apr 25, 2024191.70M-10.88%
Apr 24, 2024215.10M-3.24%
Apr 23, 2024222.30M3.25%
Apr 22, 2024215.30M1.27%
Apr 19, 2024212.60M-10.90%
Apr 18, 2024238.60M1.92%
Apr 17, 2024234.10M9.19%
Apr 16, 2024214.40M-1.43%
Apr 15, 2024217.50M-3.80%
Apr 12, 2024226.10M7.51%
Apr 11, 2024210.30M-10.59%
Apr 10, 2024235.20M7.99%
Apr 9, 2024217.80M62.78%
Apr 8, 2024133.80M-8.79%
Apr 5, 2024146.70M-3.10%
Apr 4, 2024151.40M0.40%
Apr 3, 2024150.80M-0.40%
Apr 2, 2024151.40M-7.74%
Apr 1, 2024164.10M1.36%
Mar 28, 2024161.90M12.82%
Mar 27, 2024143.50M2.14%
Mar 26, 2024140.50M1.30%
Mar 25, 2024138.70M0.95%
Mar 22, 2024137.40M-2.21%
Mar 21, 2024140.50M0.64%
View and export this data all the way back to 2022. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Nautilus Biotechnology 300.24M
XOMA Corporation 298.09M
Kamada 297.72M
Immutep 296.95M
AxoGen 296.83M
CorMedix 292.15M
Pulmonx 289.80M
Nanobiotix 289.01M
Market Cap Rankings